Establishing a pathological diagnosis in degenerative dementias.

Brain Pathology
J Lowe

Abstract

While clinicopathological studies have confirmed that Alzheimer's disease (AD) is the most common neurodegenerative cause of dementia, these same studies have also revealed that other degenerative pathologies account for a significant proportion of patients with cognitive decline. Because pathological assessment of non-Alzheimer neurodegenerative diseases now demands routine use of a costly panel of immunohistochemical techniques a scheme for staged examination of brain tissue has been developed. This scheme is weighted to initially screen out cases of Alzheimer's disease, dementia with Lewy bodies and vascular dementia using conventional staining methods and established diagnostic protocols, bringing in immunochemical techniques to discriminate between non-Alzheimer degenerative dementias. Diagnosis of pathologies causing the clinical syndrome of frontotemporal dementia can be ascertained using conventional staining supplemented by immunochemical detection of ubiquitin, tau protein and alpha beta crystallin. The diagnosis of prion disease is reliably confirmed by immunohistochemical detection of prion protein. This morphological assessment complements emerging genetic insights into many of these neurodegenerative diseases.

References

Feb 1, 1995·Journal of the American Geriatrics Society·E M AlexanderE B Larson
Dec 1, 1995·Neuropathology and Applied Neurobiology·M Tolnay, A Probst
Jan 1, 1996·Acta Neuropathologica·M Jackson, J Lowe
Jan 1, 1997·Neurology·J Corey-BloomL J Thal
Dec 1, 1996·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·M JacksonJ Lowe
Apr 18, 1998·Brain Pathology·D W Dickson
Apr 18, 1998·Brain Pathology·K A Jellinger, C Bancher
Apr 18, 1998·Brain Pathology·K A Jellinger

❮ Previous
Next ❯

Citations

Mar 24, 2005·Annals of Neurology·David S KnopmanRonald C Petersen
Mar 23, 2001·Acta Neurologica Scandinavica. Supplementum·J Sáez-ValeroD H Small
Oct 3, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·James H BowerWalter A Rocca
Oct 27, 2007·Neuropathology and Applied Neurobiology·E KuusistoI Alafuzoff
Mar 29, 2003·Neuropathology and Applied Neurobiology·G G KovacsH Budka
Jul 24, 2003·Brain : a Journal of Neurology·Keith A JosephsTamas Revesz
Feb 7, 2007·Journal of Neuropathology and Experimental Neurology·Keith A JosephsDennis W Dickson
Mar 9, 2005·Acta Neuropathologica·Keith A JosephsDennis W Dickson
Aug 13, 2004·Neuropathology and Applied Neurobiology·K A JosephsT Revesz
Jun 21, 2007·Acta Neuropathologica·Nigel J CairnsUNKNOWN Consortium for Frontotemporal Lobar Degeneration
Aug 10, 2000·Neuropathology and Applied Neurobiology·M W Head, J E Goldman
Feb 26, 2010·Neurocase·J NarvidK Rankin
Jan 22, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jakub GolabCord Naujokat
Jun 28, 2005·Biochemical and Biophysical Research Communications·Armin GieseHans Kretzschmar
Aug 3, 2010·Biochimica Et Biophysica Acta·Ashok N Hegde, Sudarshan C Upadhya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
M D GreiciusB L Miller
International Psychogeriatrics
Nicola T Lautenschlager, Ralph N Martins
Neuropathology : Official Journal of the Japanese Society of Neuropathology
Richard A ArmstrongNigel J Cairns
© 2022 Meta ULC. All rights reserved